报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 72.69% | 1.84% | -0.08% | 18/129 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
2024-06-30 | 72.75% | 1.41% | 1.02% | 20/129 | 53.65% | 佰仁医疗 | 89.27% | 行业排名> |
2024-03-31 | 72.01% | 1.91% | 1.05% | 25/129 | 53.62% | 佰仁医疗 | 89.28% | 行业排名> |
2023-12-31 | 71.27% | 0.09% | -0.16% | 24/129 | 53.83% | 正海生物 | 89.9% | 行业排名> |
2023-09-30 | 71.38% | 0.55% | -0.5% | 22/129 | 54.06% | 正海生物 | 90.39% | 行业排名> |
2023-06-30 | 71.73% | 1.93% | 1.51% | 20/129 | 53.61% | 正海生物 | 90.3% | 行业排名> |
2023-03-31 | 70.67% | 1.28% | -0.76% | 23/129 | 53.66% | 正海生物 | 89.78% | 行业排名> |
2022-12-31 | 71.2% | 2.47% | 0.3% | 23/129 | 54.04% | 三友医疗 | 90.18% | 行业排名> |
2022-09-30 | 70.99% | 1.61% | 0.87% | 25/129 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
2022-06-30 | 70.38% | 0.37% | 0.86% | 26/129 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
2022-03-31 | 69.77% | -0.73% | 0.41% | 30/129 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
2021-12-31 | 69.49% | -1.23% | -0.54% | 37/129 | 57.38% | 三友医疗 | 90.5% | 行业排名> |
2021-09-30 | 69.87% | 0.04% | -0.35% | 32/129 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
2021-06-30 | 70.11% | 2.25% | -0.25% | 38/129 | 58.42% | 正海生物 | 90.78% | 行业排名> |
2021-03-31 | 70.29% | 2% | -0.09% | 33/129 | 60.75% | 正海生物 | 91.59% | 行业排名> |
2020-12-31 | 70.36% | -0.65% | 0.74% | 42/129 | 59.67% | 正海生物 | 92.23% | 行业排名> |
2020-09-30 | 69.84% | 2% | 1.86% | 29/129 | 61.59% | 正海生物 | 92.69% | 行业排名> |
2020-06-30 | 68.57% | 2% | -3.17% | 38/129 | 59.94% | 正海生物 | 92.61% | 行业排名> |
2019-12-31 | 70.82% | 2.96% | 2.96% | 33/129 | 56.37% | 正海生物 | 94.38% | 行业排名> |
2018-12-31 | 68.78% | -0.05% | -0.05% | 35/129 | 55.53% | 正海生物 | 93.12% | 行业排名> |
2017-12-31 | 68.81% | 2% | 2% | 32/129 | 55.34% | 正海生物 | 93.78% | 行业排名> |